Versantis AG
Zurich, CH· latest recorded location
Versantis AG is named on 3 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 3
- Published applications
- 4
- Inventors
- 6
- Granted in 2026 so far
- 0
- Most recent grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
By publication year.
Technology areas
Share of 7 documents
Recent patents
- Method for preparing transmembrane pH-gradient vesicles30 Sep 2025US 12,427,112 B2
- Method for treating a metabolite toxicopathy13 Feb 2024US 11,896,712 B2
- Method for preparing transmembrane pH-gradient vesicles5 Jul 2022US 11,376,218 B2
- Use of transmembrane ph gradient liposomes for treating hyperammonemic crisis associated with inborn errors of metabolism6 Nov 2025US 2025/0339393 A1
- Unsaturated Hydroxamic Acid Derivatives and Their Use for the Treatment and Prevention of an Ammonia-Associated Disease or Disorder5 Sep 2024US 2024/0293344 A1
- Method for Preparing Transmembrane pH-Gradient Vesicles15 Sep 2022US 2022/0287971 A1
- Method for Preparing Transmembrane pH-Gradient Vesicles19 Apr 2018US 2018/0104189 A1
Most cited
By later US patents